October

hidden

References

hidden

Background
Transportation industry statistics from the United States and reports from US researchers indicate an increase in injury and mortality rates for older male motorcyclists.[1-3] Although Canadian statistics are not as readily available, the Canada Safety Council cites an average age of 46 among motorcycle buyers and has seen an increase in the age of riders in their training programs.[4] 

Three new oral anticoagulants (NOACs) are now on the market in Canada for use in patients with nonvalvular atrial fibrillation. The agents are dabigatran, rivaroxaban, and apixaban. Standing in the wings awaiting Health Canada approval is edoxaban. (While the term target-specific oral anticoagulants, or TSOACs, is also used for these agents, we will use the more familiar term NOACs in this article.)

Many physicians are skep-tical about using corticosteroid injection to manage treatment for workers and other patients suffering from lateral epicondyle tendinopathy (tennis elbow). These doubts are well founded, based on com-pelling evidence regarding the long-term outcomes for tennis elbow sufferers who are being treated with corticoster-oids.

hidden

References